Image (Image 1)
Selarsdi Injection, Solution
Product Images NDC 51759-607
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 28 technical images submitted to the FDA as part of the official labeling for Selarsdi (NDC 51759-607). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (Image 10)
Image (Image 11)
Image (Image 12)
Image (Image 13)
Image (Image 14)
A (Image 15)
B (Image 16)
C (Image 17)
D (Image 18)
E (Image 19)
Image (Image 2)
F (Image 20)
G (Image 21)
H (Image 22)
I (Image 23)
J (Image 24)
1 (Image 25)
This text appears to be a description of a medication, specifically an injection of ustekinumab with a concentration of 45 mg per 0.5 mL. The text also mentions the dosage information and the method of administration with a syringe. It outlines details about the injection procedure and may contain instructions or precautions related to the medication.*
1 (Image 26)
1 (Image 27)
This text appears to be a medication label with details about an injection containing gustekmumab. The injection is provided in a 130 mg/26 mL concentration for intravenous infusion only. The label includes instructions for pharmacists, mentioning that only one single-dose vial is included. It is important that the patient receives the enclosed medication under supervision. The medication is associated with a pharmaceutical company named Teva.*
1 (Image 28)
Image (Image 3)
1 (Image 4)
This text provides information about the percentage of participants in a study receiving different treatments: Placebo, Ustekinumab 45 mg, and Ustekinumab 90 mg. The study seems to involve a total of 615 participants (206 in the placebo group, 205 in the Ustekinumab 45 mg group, and 204 in the Ustekinumab 90 mg group).*
Image (Image 5)
This appears to be a description of various components of a medical device, possibly a syringe or injector. It includes terms like Needle Guard, Activation Clips, Viewing, Plunger Body, Plunger Label, Needle, Wings Cover. The text seems to indicate different parts or features of the device, likely for assembly or usage instructions.*
Image (Image 6)
This text appears to list different medical supplies and equipment. It mentions items such as adhesive antiseptic cotton balls, bandage wipes, gauze pads, prefilled sharps syringe disposal container, and a reference to FDA clearance. It seems to be a description of items commonly used in medical treatment and disposal of medical waste.*
Image (Image 7)
Image (Image 8)
Image (Image 9)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
